Headquartered in Hyderabad – India, Waterley Pharmaceuticals is led by a team of dynamic professionals with rich experience acquired through their work at the world’s leading healthcare companies.
With millions of people in dire need of new medical solutions, Waterley Pharmaceuticals aims to help as many people as possible, with special focus on the gastro-intestinal therapy area. Providing innovative and effective formulations that are easily accessible to all patients is our goal.
Gastrointestinal diseases in Asian populations have been a major health issue during the past two decades. The incidence and prevalence rates have shown a notable rise, with the consequence that GI diseases are increasingly the cause of morbidity and mortality in Asian countries.
In the present scenario, while diseases like diarrhoeas, hepatitis, typhoid, TB of the intestinal tract etc. are still prevalent, there is an alarming is the rise of lifestyle diseases like Irritable Bowel syndrome (IBS), Gastroesophageal reflux disease (GERD), inflammatory bowel disease like Crohn’s and non-alcoholic fatty liver and cancers of the food pipe, colon and liver, pancreas and gallbladder.
Waterley Pharmaceuticals sees opportunities in this growing gastrointestinal therapy segment in India and neighbouring Asian countries. The company markets innovative, high quality medications to meet the evolving challenges and unmet needs of patients.